Outlook Therapeutics, Inc. (OTLK) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 0.22 and resistance at 0.35. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.

📊 Technical Summary

The latest close for Outlook Therapeutics, Inc. (OTLK) came in at 0.25 (-2.34%). The chart is still trading below both the 50-day and 200-day moving averages, leaving the overall technical backdrop under pressure for now. 20-day momentum is notably strong at +19.05%; price is trading in the lower part of its roughly 52-week range (0.20–2.97); and ATR14 volatility is elevated at roughly 15.37% of price. RSI(14) stands around 43.2, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Near-term structure is defined by support at 0.22 and resistance at 0.35. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 1.51M · Net income: -23.06M · EPS (basic): -0.38. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more